The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.
Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa
Open accessAbstract
The bronchial microbiome in severe COPD during stability and exacerbation in patients chronically colonised by Pseudomonas aeruginosa (PA), has not been defined. Our objective was to determine the characteristics of the bronchial microbiome of severe COPD patients colonised and not colonised by P. aeruginosa and its changes during exacerbation. COPD patients with severe disease and frequent exacerbations were categorised according to chronic colonisation by P. aeruginosa. Sputum samples were obtained in stability and exacerbation, cultured, and analysed by 16S rRNA gene amplification and pyrosequencing. Sixteen patients were included, 5 of them showing chronic colonisation by P. aeruginosa. Pseudomonas genus had significantly higher relative abundance in stable colonised patients (p = 0.019), but no significant differences in biodiversity parameters were found between the two groups (Shannon, 3 (2-4) vs 3 (2-3), p = 0.699; Chao1, 124 (77-159) vs 140 (115-163), p = 0.364). In PA-colonised patients bronchial microbiome changed to a microbiome similar to non-PA-colonised patients during exacerbations. An increase in the relative abundance over 20 % during exacerbation was found for Streptococcus, Pseudomonas, Moraxella, Haemophilus, Neisseria, Achromobacter and Corynebacterium genera, which include recognised potentially pathogenic microorganisms, in 13 patients colonised and not colonised by P. aeruginosa with paired samples. These increases were not identified by culture in 5 out of 13 participants (38.5 %). Stable COPD patients with severe disease and PA-colonised showed a similar biodiversity to non-PA-colonised patients, with a higher relative abundance of Pseudomonas genus in bronchial secretions. Exacerbation in severe COPD patients showed the same microbial pattern, independently of previous colonisation by P. aeruginosa.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“With remarkable consistency, all studies report no increase in bacterial burden and no decrease in community diversity during exacerbations.”
From The microbiome and critical illness (2016) · cites this paper as [133]
In the citing paper
“In exacerbation states, membership of the lung bacterial community shifts, often towards enrichment of the Proteobacteria phylum”
From The microbiome and critical illness (2016) · cites this paper as [133]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Mathematical Theory of Communication
Shannon, C. E. (1948) · The MIT Press eBooks · doi:10.1002/j.1538-7305.1948.tb00917.x · Cited by 50,387
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,435
An Ordination of the Upland Forest Communities of Southern Wisconsin
Bray, J. R., & Curtis, J. T. (1957) · Ecological Monographs · doi:10.2307/1942268 · Cited by 11,736
The Mathematical Theory of Communication
Shannon, C. E., Weaver, W., & Wiener, N. (1950) · Physics Today · doi:10.1063/1.3067010 · Cited by 9,885
Standardization of Spirometry, 1994 Update. American Thoracic Society
(1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.3.7663792 · Cited by 6,605
Global Initiative for Chronic Obstructive Lung Disease
Gerald, L. B., & Bailey, W. C. (2002) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200207000-00004 · Cited by 5,806
Nonparametric estimation of the number of classes in a population
Chao, A. (1984) · Scandinavian Journal of Statistics · Cited by 4,263
Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
Anthonisen, N. R., MANFREDA, J., WARREN, C. P. W., HERSHFIELD, E. S., HARDING, G. K. M., & NELSON, N. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-196 · Cited by 2,474
Mathematical Theory of Communication
Binder, M. D., Hirokawa, N., & Windhorst, U. (2008) · Springer eBooks · doi:10.1007/978-3-540-29678-2_3338 · Cited by 2,297
Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach
Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon, P., Marteau, P., et al. (2006) · Gut · doi:10.1136/gut.2005.073817 · Cited by 2,277
Disordered Microbial Communities in Asthmatic Airways
Hilty, M., Burke, C. M., Pedro, H., Cárdenas, P., Bush, A., Bossley, C. J., Davies, J. C., Ervine, A., Poulter, L. W., Pachter, L. S., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008578 · Cited by 1,874
Suau, A., Bonnet, R., Sutren, M., Godon, J.-J., Gibson, G. R., Collins, M. D., & Doré, J. (1999) · Applied and Environmental Microbiology · doi:10.1128/aem.65.11.4799-4807.1999 · Cited by 1,490
Topographical Continuity of Bacterial Populations in the Healthy Human Respiratory Tract
Charlson, E. S., Bittinger, K., Haas, A. R., Fitzgerald, A. S., Frank, I., Yadav, A., Bushman, F. D., & Collman, R. G. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201104-0655oc · Cited by 1,144
New Strains of Bacteria and Exacerbations of Chronic Obstructive Pulmonary Disease
Sethi, S., Evans, N., Grant, B. J. B., & Murphy, T. F. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012561 · Cited by 1,046
Emerson, J., Rosenfeld, M., McNamara, S., Ramsey, B. W., & Gibson, R. L. (2002) · Pediatric Pulmonology · doi:10.1002/ppul.10127 · Cited by 1,009
Analysis of the lung microbiome in the “healthy” smoker and in COPD.
Erb-Downward, J. R., Thompson, D. L., Han, M. K., Freeman, C. M., McCloskey, L., Schmidt, L. A., Young, V. B., Toews, G. B., Curtis, J. L., Sundaram, B., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016384 · Cited by 973 · cited 2×
“Although the sputum may be contaminated by bacterial flora of the oropharynx and the oral cavity, the microbiome composition that we have found in severe COPD patients is quite similar to that of previous reports in healthy controls and COPD patients based on the use of bronchial brushing and bronchoalveolar lavage fo…”
ResultGuidelines for the management of adult lower respiratory tract infections
Woodhead, M. A., Blasi, F., Ewig, S., Huchon, G., Leven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G. J. M. G., & Verheij, T. J. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00055705 · Cited by 891
Comparison of the Respiratory Microbiome in Healthy Nonsmokers and Smokers
Morris, A., Beck, J. M., Schloss, P. D., Campbell, T. B., Crothers, K., Curtis, J. L., Flores, S. C., Fontenot, A. P., Ghedin, E., Huang, L., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201210-1913oc · Cited by 822
Longitudinal Assessment ofPseudomonas aeruginosain Young Children with Cystic Fibrosis
Burns, J. L., Gibson, R. L., McNamara, S., Yim, D. L., Emerson, J., Rosenfeld, M., Hiatt, P., McCoy, K., Castile, R. G., Smith, A. L., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/318075 · Cited by 555
Spirometric reference values from a Mediterranean population.
Roca, J., Sanchis, J., Agustí-Vidal, A., Segarra, F., Navajas, D., Rodríguez-Roisin, R., Casán, P., & Sans, S. (1986) · PubMed · Cited by 499
Chapter 12: Human Microbiome Analysis
Morgan, X. C., & Huttenhower, C. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002808 · Cited by 496
Soler, N., Torres, A., Ewig, S., González, J., Celis, R., El-Ebiary, M., Hernández, C., & Rodriguez‐Roisin, R. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9711044 · Cited by 468
Hayashi, H., Sakamoto, M., & Benno, Y. (2002) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2002.tb02731.x · Cited by 458
Miravitlles, M., Espinosa, C., Fernández-Laso, E., Martos, J. A., Maldonado, J. A., & Gallego, M. (1999) · CHEST Journal · doi:10.1378/chest.116.1.40 · Cited by 443
Self-citationHill, A. T., Campbell, E. J., Hill, S. L., Bayley, D., & Stockley, R. A. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00507-6 · Cited by 413
Molyneaux, P. L., Mallia, P., Cox, M. J., Footitt, J., Willis-Owen, S. A. G., Homola, D., Trujillo-Torralbo, M.-B., Elkin, S., Kon, O. M., Cookson, W. O. C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201302-0341oc · Cited by 390
Infective Exacerbations of Chronic Bronchitis
Eller, J., Ede, A., Schaberg, T., Niederman, M. S., Mauch, H., & Lode, H. M. (1998) · CHEST Journal · doi:10.1378/chest.113.6.1542 · Cited by 371
Microbiologic Determinants of Exacerbation in Chronic Obstructive Pulmonary Disease
Rosell, A., Monsó, E., Soler, N., Torres, F., ANGRILL, J., Riise, G. C., Zalacaín, R., Morera, J., & Torres, A. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.8.891 · Cited by 302
Self-citationMicroscopic and baceriologic analysis of expectorated sputum.
Pr, M., & Washington, J. A. (1975) · PubMed · Cited by 295
Cabello, H., Torres, A., Celis, R., El-Ebiary, M., de la Bellacasa, J. P., Xaubet, A., González, J., Agustı́, C., & Soler, N. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10051137 · Cited by 284
Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease
Murphy, T. F., Brauer, A. L., Eschberger, K., Lobbins, P., Grove, L., Cai, X., & Sethi, S. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1413oc · Cited by 279
Chronic Pseudomonas aeruginosa Infection in Chronic Obstructive Pulmonary Disease
Martínez‐Solano, L., Macia, M. D., Fajardo-Lubian, A., Oliver, A., & Martínez, J. L. (2008) · Clinical Infectious Diseases · doi:10.1086/593186 · Cited by 257
Significance of the microbiome in obstructive lung disease
Han, M. K., Huang, Y. J., LiPuma, J. J., Boushey, H. A., Boucher, R. C., Cookson, W., Curtis, J. L., Erb‐Downward, J. R., Lynch, S. V., Sethi, S., et al. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-201183 · Cited by 235
Diagnóstico y tratamiento de las bronquiectasias
Vendrell, M., de Gracia, J., Olveira, C., Martínez, M. Á., Girón, R. M., Máiz, L., Cantón, R., Coll, R., Escribano, A., & Solé, A. (2008) · Archivos de Bronconeumología · doi:10.1157/13128330 · Cited by 214
Culture Enriched Molecular Profiling of the Cystic Fibrosis Airway Microbiome
Sibley, C. D., Grinwis, M. E., Field, T. R., Eshaghurshan, C. S., Faria, M. M. P., Dowd, S. E., Parkins, M. D., Rabin, H. R., & Surette, M. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022702 · Cited by 196
The Immunopathogenesis of Chronic Obstructive Pulmonary Disease: Insights from Recent Research
Curtis, J. L., Freeman, C. M., & Hogg, J. C. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200701-002fm · Cited by 190
Investigating the biological and clinical significance of human dysbioses
Frank, D. N., Zhu, W., Sartor, R. B., & Li, E. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.06.005 · Cited by 182
Respiratory Infections With Pseudomonas aeruginosa in Children With Cystic Fibrosis
West, S. E. H., Zeng, L., Lee, B. L., Kosorok, M. R., Laxova, A., Rock, M. J., Splaingard, M., & Farrell, P. M. (2002) · JAMA · doi:10.1001/jama.287.22.2958 · Cited by 182
Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study
García‐Vidal, C., Almagro, P., Romaní, V., Rodríguez‐Carballeira, M., Cuchí, E., Canales, L., Blasco, D. P., Heredia, J. L., & Garau, J. (2009) · European Respiratory Journal · doi:10.1183/09031936.00003309 · Cited by 156
Cantón, R., Cobos, N., de Gracia, J., Baquero, F., Honorato, J., Gärtner, S., Alvarez, A., Salcedo, A., Oliver, A., & Garcia-Quetglas, E. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01217.x · Cited by 155
Orriols, R., Roig, J., Ferrer, J., Sampol, G., Rosell, A., Marcellés, A. F., & Vallano, A. (1999) · Respiratory Medicine · doi:10.1016/s0954-6111(99)90090-2 · Cited by 155
Microbial diversity in the sputum of a cystic fibrosis patient studied with 16S rDNA pyrosequencing
Armougom, F., Bittar, F., Stremler, N., Rolain, J., Robert, C., Dubus, J. ‐., Sarles, J., Raoult, D., & Scola, B. L. (2009) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0749-x · Cited by 93
Therapeutic correction of bacterial dysbiosis discovered by molecular techniques
Sartor, R. B. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809363105 · Cited by 89
Pseudomonal Infections in Patients with COPD
Lieberman, D. B., & Lieberman, D. (2003) · American Journal of Respiratory Medicine · doi:10.1007/bf03256673 · Cited by 80
Bacterial sputum cultures. A clinician's viewpoint.
Scoy, R. E. V. (1977) · PubMed · Cited by 78
Diagnosis and Treatment of Bronchiectasis
Vendrell, M., de Gracia, J., Olveira, C., Martínez, M. Á., Girón, R. M., Máiz, L., Cantón, R., Coll, R., Escribano, A., & Solé, A. (2008) · Archivos de Bronconeumología · doi:10.1016/s1579-2129(08)60117-2 · Cited by 78
Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations
Pomares, X., Montón, C., Espasa, M., Salas, J. C., Monsó, E., & Gallego, M. (2011) · International Journal of COPD · doi:10.2147/copd.s23655 · Cited by 76
Self-citationNegro, R. D., Micheletto, C., Tognella, S., Visconti, M., & Turati, C. (2008) · Advances in Therapy · doi:10.1007/s12325-008-0105-2 · Cited by 65
Pseudomonas aeruginosaPopulation Biology in Chronic Obstructive Pulmonary Disease
Rakhimova, E., Wiehlmann, L., Brauer, A. L., Sethi, S., Murphy, T. F., & Tümmler, B. (2009) · The Journal of Infectious Diseases · doi:10.1086/648404 · Cited by 64
Editorial Commentary:The Many Faces ofPseudomonas aeruginosain Chronic Obstructive Pulmonary Disease
Murphy, T. F. (2008) · Clinical Infectious Diseases · doi:10.1086/593187 · Cited by 43
Campbell, R. W. F. (2008) · Cardiology · doi:10.1159/000176773 · Cited by 11
Cited by
Sorted by citations
Microbiota in health and diseases
Hou, K., Wu, Z.-X., Chen, X.-Y., Wang, J.-Q., Zhang, D., Xiao, C., Zhu, D., Koya, J. B., Wei, L., Li, J., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00974-4 · Cited by 3,171
The Microbiome and the Respiratory Tract
Dickson, R. P., Erb-Downward, J. R., Martinez, F. J., & Huffnagle, G. B. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105238 · Cited by 953
The role of the microbiome in exacerbations of chronic lung diseases
Dickson, R. P., Martinez, F. J., & Huffnagle, G. B. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61136-3 · Cited by 495
Lung microbiome dynamics in COPD exacerbations
Wang, Z., Bafadhel, M., Haldar, K., Spivak, A., Mayhew, D. N., Miller, B. E., Tal‐Singer, R., Johnston, S. L., Ramsheh, M. Y., Barer, M. R., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.01406-2015 · Cited by 469
The microbiome and critical illness
Dickson, R. P. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00427-0 · Cited by 460
Metadata
- Authors
- Millares, L., Ferrari, R., Gallego, M., Garcia-Nuñez, M., Pérez-Brocal, V., Espasa, M., Pomares, X., Monton, C., Moya, A., & Monsó, E.
- Affiliations
- Universitat de València (ES)
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
- Corporació Sanitària Parc Taulí (ES)
- Universitat Autònoma de Barcelona (ES)
- Corresponding author
- Monsó, E.
- Venue
- European Journal of Clinical Microbiology & Infectious Diseases
- Published
- 2014-01-22
- Volume
- 33
- Issue
- 7
- Pages
- 1101-1111
- ISSN
- 0934-9723 (ISSN-L)
- 1435-4373
- PMC
- PMC4042013
- OpenAlex
- W2069385595
- Cited by
- 136
- References
- 57
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 14 · 2023: 8 · 2022: 16 · 2021: 9 · 2020: 12 · 2019: 14 · 2018: 15 · 2017: 16 · 2016: 13 · 2015: 8 · 2014: 4
- FWCI
- 10.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- European Journal of Clinical Microbiology & Infectious Diseases (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Ministerio de Economía y Competitividad (SAF2012, SAF 2012-31187)
- Generalitat Valenciana (Prometeo/2009/092)
- Sociedad Española de Neumología y Cirugía Torácica
- Instituto de Salud Carlos III (Marató de TV3)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- chronic obstructive pulmonary disease, COPD exacerbations, sputum microbiota, bacterial diversity, potentially pathogenic microorganisms, Streptococcus, Moraxella, Haemophilus, Neisseria, Corynebacterium, Achromobacter
- MeSH terms
- Aged, Aged, 80 and over, Bronchi, DNA, Bacterial, DNA, Ribosomal, Female, Humans, Male, Middle Aged, Molecular Sequence Data, Phylogeny, RNA, Ribosomal, 16S, Sputum, Cohort Studies, Cluster Analysis, Sequence Analysis, DNA, Pulmonary Disease, Chronic Obstructive, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review